The expert panel agreed it was time to use the same strain in both the primary and booster doses of the COVID-19 vaccine ...

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

The Food and Drug Administration’s (FDA) advisory panel on vaccines is set to consider an annual schedule for the coronavirus ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The CDC and FDA announced ... the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over, but said they were continuing to recommend the shots. The surveillance ...

The advisory panel mostly agreed with the FDA ... kids of immigrants COVID-19 vaccines have saved millions of lives and ...

The FDA's vaccine advisors unanimously backed the agency's proposal to harmonize COVID-19 primary and booster vaccines to ...

WPTV looked into what makes the COVID-19 vaccine series complicated for many people, and the impact a model similar to annual ...

This safety concern has not been identified with Moderna's (MRNA.O) bivalent shot and both the CDC and FDA continue to recommend ... EU may pay more for Pfizer COVID shots in return for lower ...

But the FDA believes the time is right for annual shots targeting the latest COVID-19 variants, even though Peter Marks, M.D.

The vote means young children and others who haven't been vaccinated may soon be eligible to receive two-strain vaccines that ...